[1]

[2]

SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.

[3]

LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.

[4]

YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.

[5]

XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.

[6]

CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.

[7]

. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.

[8]

. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.

[9]

[10]

YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.

[11]

DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.

[12]

GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.

[13]

. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.

[14]

. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.

[15]

. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

组别	抗凝管	即刻	0.5 h	1 h	2 h	4 h
离心前	肝素钠-氟化钠管	6.05±1.09	5.60±1.00^*#	5.52±0.98^*#	5.38±0.97^*#	5.37±0.96^*#
	酸化氟化钠管	6.04±1.09	6.03±1.09	6.02±1.08	6.05±1.10	6.03±1.09
离心后	肝素钠-氟化钠管	5.29±0.98	5.25±1.00	5.32±1.01	5.35±1.00	5.24±1.02
	酸化氟化钠管	5.32±0.96	5.30±0.97	5.36±0.98	5.28±0.96	5.34±0.98

组别	抗凝管	即刻	0.5 h	1 h	2 h	4 h
离心前	肝素钠-氟化钠管	6.05±1.09	5.60±1.00^*#	5.52±0.98^*#	5.38±0.97^*#	5.37±0.96^*#
	酸化氟化钠管	6.04±1.09	6.03±1.09	6.02±1.08	6.05±1.10	6.03±1.09
离心后	肝素钠-氟化钠管	5.29±0.98	5.25±1.00	5.32±1.01	5.35±1.00	5.24±1.02
	酸化氟化钠管	5.32±0.96	5.30±0.97	5.36±0.98	5.28±0.96	5.34±0.98

组别	即刻	0.5 h	1 h	2 h	4 h
离心前	-0.012±0.024	0.425±0.052^*	0.507±0.045^*	0.667±0.043^*	0.668±0.034^*
离心后	-0.032±0.017	-0.052±0.037	-0.040±0.032	0.064±0.031	-0.098±0.024

组别	即刻	0.5 h	1 h	2 h	4 h
离心前	-0.012±0.024	0.425±0.052^*	0.507±0.045^*	0.667±0.043^*	0.668±0.034^*
离心后	-0.032±0.017	-0.052±0.037	-0.040±0.032	0.064±0.031	-0.098±0.024

RichHTML

PDF (PC)

[1]	张卫民,刘树业.正确的标本采集是准确检测结果的开始[J].中华检验医学杂志,2013,36(1):90-91.
[2]	BRUNS DE,KNOWLER WC.Stabilization of glucose in blood samples: why it matters[J]. Clin Chem,2009,55(5):850-852.
[3]	田亚平,邱彩琴.血糖测定的方法学进展与临床应用[J].中华检验医学杂志,2008,31(3):355-360.
[4]	GAMBINO R, PISCITELLI J, ACKATTUPATHIL TA, et al.Acidification of biood is superior to sodium fluoride alone as an inhibitor of glycolysis[J]. Clin Chem,2009,55(5):1019-1021.
[5]	张吟眉,王京,李国权.草酸钠-氟化钠采血管中血样离心前放置时间对血浆葡萄糖测定的影响[J].检验医学与临床,2013,10(4):429-430.
[6]	YAGMUR E, VAN HELDEN J, KOCH A, et al.Effective inhibition of glycolysis in venous whole blood and plasma samples[J].Laboratoriumsmedizin, 2012, 36(3):169-177.